Troglitazone
Generic medicine reference
Not yet clinically reviewed
This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.
Overview
An oral hypoglycemic used for the treatment of type-II diabetes mellitus. Troglitazone has been associated with severe hepatic reactions, which has led to the withdrawal of this drug in the UK.
Indications
Troglitazone is primarily indicated in conditions like Diabetes insipidus.
Contraindications
Troglitazone is contraindicated in conditions like Diabetes mellitus, Hypersensitivity, Pregnancy.
Side Effects
The symptomatic adverse reactions produced by Troglitazone are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Fatigue, Nausea, Vomiting, Diarrhea, Malaise, Musculoskeletal pain.
Warnings
It should be used with caution in patients with heart failure. Regular monitoring of liver function during therapy and withdrawal of drug in any patient who develops jaundice or sign of liver dysfunction is required.
High Risk Groups
Drug should not be given to Pediatrics, and Pregnant Mothers. If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
No adult dosage information is recorded for this medicine yet.
Child Dosage
No child dosage information is recorded for this medicine yet.
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
No data regarding the interactions of Troglitazone was found.
Storage
Tab Store Between 20°C-25°C. Protect from Moisture.
Available Brands in Pakistan
No brands are recorded for this generic.